When gefitinib-resistant CRC was treated with the antiproliferative agent nano-diamino-tetrac (NDAT), proliferation was abrogated via inhibition of ST6Gal1 (Chang et al., 2018). The gene discussed is ST6GAL1; the disease is colorectal carcinoma.